Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2023
Historique:
medline: 23 10 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: ppublish

Résumé

Neurofilament light chain (NfL) is a marker of neuronal injury. Perivascular spaces (PVS) visible on magnetic resonance imaging (MRI) represent cerebral small vessel disease (CSVD) but their role as markers of neuronal injury needs further clarification. To relate PVS burden according to brain topography and plasma NfL. Framingham Heart Study (FHS) participants with brain MRI and NfL measurements were included. PVS were rated in the basal ganglia (BG) and centrum semiovale (CSO) using validated methods and categorized based on counts. A mixed region variable representing high burden PVS in either BG or CSO was assessed. Multivariable linear regression analyses were used to relate PVS burden to log-transformed NfL levels in models adjusted for age, sex, FHS cohort, time between MRI and clinic exam, and image view (model 1), vascular risk factors (model 2), and white matter hyperintensity volume, covert brain infarcts, and cerebral microbleeds (model 3). Among 1,457 participants (68.1±8.5 years, 45% males), NfL levels increased with higher PVS burden. Multivariable analysis showed an association of high PVS burden strictly in BG with NfL (β= 0.117, 95% CI 0.014-0.221; p = 0.027), but attenuated in model 3. The associations were mainly in participants≥65 years (β= 0.122, 95% CI 0.015-0.229, p = 0.026), women (β= 0.156, 95% CI 0.024-0.288, p = 0.021), and APOE ɛ4 non-carriers (β= 0.140, 95% CI 0.017-0.263, p = 0.026). The association of strictly BG high PVS burden with NfL suggests a role for PVS as markers of neuroaxonal injury, but our results are hypothesis generating and require further replication.

Sections du résumé

BACKGROUND
Neurofilament light chain (NfL) is a marker of neuronal injury. Perivascular spaces (PVS) visible on magnetic resonance imaging (MRI) represent cerebral small vessel disease (CSVD) but their role as markers of neuronal injury needs further clarification.
OBJECTIVE
To relate PVS burden according to brain topography and plasma NfL.
METHODS
Framingham Heart Study (FHS) participants with brain MRI and NfL measurements were included. PVS were rated in the basal ganglia (BG) and centrum semiovale (CSO) using validated methods and categorized based on counts. A mixed region variable representing high burden PVS in either BG or CSO was assessed. Multivariable linear regression analyses were used to relate PVS burden to log-transformed NfL levels in models adjusted for age, sex, FHS cohort, time between MRI and clinic exam, and image view (model 1), vascular risk factors (model 2), and white matter hyperintensity volume, covert brain infarcts, and cerebral microbleeds (model 3).
RESULTS
Among 1,457 participants (68.1±8.5 years, 45% males), NfL levels increased with higher PVS burden. Multivariable analysis showed an association of high PVS burden strictly in BG with NfL (β= 0.117, 95% CI 0.014-0.221; p = 0.027), but attenuated in model 3. The associations were mainly in participants≥65 years (β= 0.122, 95% CI 0.015-0.229, p = 0.026), women (β= 0.156, 95% CI 0.024-0.288, p = 0.021), and APOE ɛ4 non-carriers (β= 0.140, 95% CI 0.017-0.263, p = 0.026).
CONCLUSIONS
The association of strictly BG high PVS burden with NfL suggests a role for PVS as markers of neuroaxonal injury, but our results are hypothesis generating and require further replication.

Identifiants

pubmed: 37661877
pii: JAD221260
doi: 10.3233/JAD-221260
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1133-1145

Subventions

Organisme : NHLBI NIH HHS
ID : N01 HC025195
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS017950
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG059725
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG038444
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG048180
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010129
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072972
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054076
Pays : United States

Auteurs

Oluchi Ekenze (O)

Graduate Medical Sciences, Boston University School of Medicine, Boston, MA, USA.
NHLBI's Framingham Heart Study, Framingham, MA, USA.

Adlin Pinheiro (A)

NHLBI's Framingham Heart Study, Framingham, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Serkalem Demissie (S)

NHLBI's Framingham Heart Study, Framingham, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Hugo J Aparicio (HJ)

NHLBI's Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Andreas Charidimou (A)

Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Alexa S Beiser (AS)

NHLBI's Framingham Heart Study, Framingham, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Claudia L Satizabal (CL)

NHLBI's Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.
Department of Population Health Sciences, UT Health San Antonio, San Antonio, TX, USA.

Tiffany Kautz (T)

The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.

Charles DeCarli (C)

Department of Neurology, University of California at Davis, Davis, CA, USA.

Steven Greenberg (S)

Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, MA, USA.

Sudha Seshadri (S)

NHLBI's Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.

Jose R Romero (JR)

NHLBI's Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH